bf/NASDAQ:CCRN_icon.jpeg

NASDAQ:CCRN

Cross Country Healthcare, Inc.

  • Stock

USD

Last Close

14.75

16/05 20:00

Market Cap

769.45M

Beta: 0.98

Volume Today

390.53K

Avg: 645.90K

PE Ratio

6.94

PFCF: 3.09

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
35.64M
-
6.12M
82.83%
5.30M
13.42%
5.32M
0.50%
5.71M
7.19%
5.75M
0.72%
6.15M
7.05%
5.78M
6.12%
6.55M
13.43%
9.36M
42.83%
5.53M
40.87%
average payables
10.20M
-
18.79M
84.23%
34.21M
82.01%
49.97M
46.08%
54.72M
9.51%
47.17M
13.79%
44.73M
5.16%
47.80M
6.85%
79.81M
66.97%
147.63M
84.97%
92.75M
37.17%
average receivables
68.83M
-
93.99M
36.55%
134.40M
42.99%
163.20M
21.43%
176.88M
8.38%
173.71M
1.79%
172.43M
0.74%
174.62M
1.27%
336.83M
92.89%
579.46M
72.03%
516.16M
10.92%
book value per share
5.74
-
4.16
27.48%
4.47
7.33%
4.71
5.32%
6.77
43.84%
6.10
9.89%
4.54
25.57%
4.28
5.80%
8.11
89.57%
12.35
52.33%
13.34
8.02%
capex per share
-0.06
-
-0.15
159.59%
-0.07
48.86%
-0.20
170.81%
-0.15
28.09%
-0.13
11.67%
-0.08
36.33%
-0.13
55.79%
-0.20
52.82%
-0.24
21.47%
-0.39
65.93%
capex to depreciation
-0.28
-
-0.61
116.84%
-0.29
52.33%
-0.71
142.56%
-0.50
29.28%
-0.39
22.32%
-0.21
46.47%
-0.36
74.37%
-0.73
99.82%
-0.70
4.00%
-0.76
9.02%
capex to operating cash flow
-0.20
-
1.12
655.23%
-0.13
111.54%
-0.22
67.03%
-0.11
48.09%
-0.22
94.94%
-0.53
142.31%
-0.17
68.02%
0.08
149.36%
-0.07
178.27%
-0.06
14.20%
capex to revenue
-0.00
-
-0.01
85.24%
-0.00
58.40%
-0.01
154.22%
-0.01
24.49%
-0.01
4.71%
-0.00
36.49%
-0.01
54.31%
-0.00
22.50%
-0.00
26.80%
cash per share
0.26
-
0.16
38.35%
0.08
51.40%
0.64
724.84%
0.73
13.58%
0.45
38.40%
0.03
93.59%
0.04
53.87%
0.03
36.31%
0.10
244.84%
0.48
394.84%
days of inventory on hand
6.92
-
4.82
30.41%
2.89
39.93%
3.65
26.26%
3.03
17.04%
3.73
23.14%
3.60
3.58%
3.14
12.71%
2.14
31.75%
1.85
13.56%
days payables outstanding
11.54
-
21.67
87.77%
26.31
21.42%
35.10
33.39%
29.02
17.34%
26.31
9.34%
27.00
2.62%
28.73
6.42%
30.78
7.13%
31.08
0.97%
days sales outstanding
57.40
-
70.34
22.55%
71.22
1.25%
77.36
8.62%
74.73
3.40%
76.14
1.89%
77.48
1.77%
76.24
1.61%
108.62
42.48%
85.83
20.98%
debt to assets
0.03
-
0.23
560.38%
0.25
7.75%
0.22
8.73%
0.21
5.40%
0.19
8.10%
0.25
27.44%
0.20
17.45%
0.27
30.18%
0.17
37.61%
0.01
95.34%
debt to equity
0.05
-
0.57
1,084.10%
0.64
11.88%
0.58
9.83%
0.42
27.33%
0.38
8.55%
0.58
52.64%
0.47
18.81%
0.66
38.66%
0.35
47.49%
0.01
96.78%
dividend yield
0.00
-
earnings yield
-0.11
-
-0.08
26.94%
0.01
110.48%
0.02
85.70%
0.08
428.55%
-0.06
177.25%
-0.13
107.27%
-0.04
71.78%
0.13
441.68%
0.19
47.86%
0.09
52.81%
enterprise value
309.99M
-
458.33M
47.85%
603.94M
31.77%
567.97M
5.95%
520.43M
8.37%
328.53M
36.87%
510.06M
55.26%
391.65M
23.21%
1.21B
209.70%
1.14B
6.21%
791.35M
30.43%
enterprise value over ebitda
41.54
-
27.26
34.39%
16.59
39.12%
13.48
18.78%
12.60
6.51%
11.04
12.36%
23.06
108.84%
13.67
40.71%
7.56
44.72%
3.73
50.62%
6.12
63.95%
ev to operating cash flow
35.80
-
-112.56
414.41%
33.12
129.42%
18.84
43.11%
11.44
39.30%
15.65
36.82%
92.04
488.22%
14.40
84.36%
-14.17
198.40%
8.49
159.90%
3.18
62.47%
ev to sales
0.71
-
0.74
4.89%
0.79
6.08%
0.68
13.41%
0.60
11.71%
0.40
33.12%
0.62
54.17%
0.47
24.52%
0.72
54.50%
0.41
43.97%
free cash flow per share
0.22
-
-0.28
224.38%
0.50
281.76%
0.74
45.96%
1.15
56.91%
0.46
60.13%
0.07
84.20%
0.63
761.57%
-2.53
504.04%
3.38
233.82%
6.61
95.33%
free cash flow yield
0.02
-
-0.02
199.47%
0.03
238.40%
0.05
53.26%
0.09
91.96%
0.06
30.60%
0.01
90.04%
0.07
1,028.69%
-0.09
229.10%
0.13
239.82%
0.29
129.24%
graham net net
-0.25
-
-3.13
1,157.98%
-3.42
9.39%
-2.50
26.82%
-1.97
21.29%
-1.74
11.78%
-2.34
34.82%
-1.85
21.08%
-1.53
17.12%
0.36
123.79%
2.55
599.53%
graham number
12.00
-
9.77
18.60%
3.75
61.57%
5.12
36.48%
12.77
149.29%
8.08
36.77%
12.63
56.39%
5.69
54.95%
25.62
350.24%
37.62
46.83%
24.79
34.10%
income quality
-0.17
-
0.13
177.50%
3.68
2,750.50%
3.45
6.20%
1.17
66.03%
-1.34
213.91%
-0.10
92.58%
-2.24
2,161.63%
-0.65
71.05%
0.71
209.66%
3.42
381.01%
intangibles to total assets
0.59
-
0.50
14.68%
0.49
2.82%
0.39
19.57%
0.44
12.23%
0.41
5.75%
0.40
3.96%
0.37
7.17%
0.23
37.94%
0.22
4.13%
0.28
27.39%
interest coverage
-9.45
-
-2.52
73.37%
3.02
220.01%
1.01
66.46%
2.79
175.27%
-2.28
181.71%
1.52
166.54%
5.53
264.59%
20.29
267.11%
18.98
6.46%
13.93
26.62%
interest debt per share
0.30
-
2.51
725.25%
3.07
22.31%
2.90
5.53%
2.95
1.83%
2.49
15.59%
2.80
12.33%
2.11
24.71%
5.52
161.75%
4.65
15.67%
0.38
91.90%
inventory turnover
52.71
-
75.75
43.71%
126.09
66.46%
99.87
20.80%
120.38
20.54%
97.76
18.79%
101.40
3.72%
116.17
14.57%
170.20
46.51%
196.88
15.68%
invested capital
0.05
-
0.57
1,084.10%
0.64
11.88%
0.58
9.83%
0.42
27.33%
0.38
8.55%
0.58
52.64%
0.47
18.81%
0.66
38.66%
0.35
47.49%
0.01
96.78%
market cap
309.47M
-
389.25M
25.78%
516.51M
32.69%
501.58M
2.89%
446.83M
10.92%
261.37M
41.51%
416.17M
59.23%
320.10M
23.08%
1.02B
218.18%
983.41M
3.44%
803.18M
18.33%
net current asset value
13.40M
-
-63.62M
574.69%
-66.01M
3.76%
-30.96M
53.09%
-21.08M
31.92%
-13.90M
34.06%
-35.52M
155.52%
-18.95M
46.64%
72.99M
485.12%
185.05M
153.53%
209.23M
13.06%
net debt to ebitda
0.07
-
4.11
5,783.57%
2.40
41.53%
1.58
34.41%
1.78
13.10%
2.26
26.70%
4.24
88.05%
2.50
41.15%
1.21
51.49%
0.51
58.27%
-0.09
118.08%
net income per share
-1.12
-
-1.02
8.64%
0.14
113.76%
0.25
76.86%
1.07
332.05%
-0.48
144.38%
-1.56
228.57%
-0.34
78.46%
3.60
1,169.34%
5.09
41.53%
2.05
59.79%
operating cash flow per share
0.28
-
-0.13
146.75%
0.58
543.21%
0.94
62.13%
1.30
38.52%
0.59
54.69%
0.15
73.72%
0.75
387.16%
-2.33
409.57%
3.62
255.20%
7.00
93.40%
payables turnover
31.62
-
16.84
46.74%
13.87
17.64%
10.40
25.03%
12.58
20.97%
13.87
10.30%
13.52
2.55%
12.70
6.03%
11.86
6.65%
11.75
0.96%
receivables turnover
6.36
-
5.19
18.40%
5.13
1.24%
4.72
7.93%
4.88
3.52%
4.79
1.85%
4.71
1.73%
4.79
1.63%
3.36
29.81%
4.25
26.55%
research and ddevelopement to revenue
return on tangible assets
-0.34
-
-0.20
41.84%
0.02
112.01%
0.03
43.42%
0.14
324.33%
-0.07
147.36%
-0.24
258.54%
-0.05
77.80%
0.23
533.49%
0.25
9.04%
0.15
41.74%
revenue per share
14.13
-
19.81
40.14%
24.35
22.94%
25.94
6.53%
24.70
4.77%
22.90
7.31%
22.96
0.26%
23.18
0.96%
45.70
97.17%
75.83
65.93%
roe
-0.19
-
-0.24
25.98%
0.03
112.82%
0.05
67.94%
0.16
200.37%
-0.08
149.25%
-0.34
341.43%
-0.08
77.13%
0.44
664.08%
0.41
7.09%
0.15
62.78%
roic
-0.16
-
-0.05
67.26%
0.11
305.39%
0.05
53.03%
0.32
532.24%
-0.04
111.74%
0.07
278.43%
0.06
3.65%
0.27
327.24%
0.32
18.42%
0.16
48.91%
sales general and administrative to revenue
0.24
-
0.23
6.38%
0.21
7.93%
0.22
2.65%
0.22
0.44%
0.22
1.88%
shareholders equity per share
5.74
-
4.16
27.48%
4.47
7.33%
4.71
5.32%
6.77
43.84%
6.10
9.89%
4.54
25.57%
4.28
5.80%
8.11
89.57%
12.35
52.33%
13.34
8.02%
stock based compensation to revenue
0.00
-
0.00
53.14%
0.00
42.79%
0.00
26.46%
0.00
16.35%
0.00
7.17%
0.00
5.67%
0.01
56.40%
0.00
36.35%
0.00
35.94%
tangible asset value
32.29M
-
-32.34M
200.16%
-36.67M
13.38%
-83K
99.77%
32.45M
39,198.80%
41.55M
28.05%
11.58M
72.14%
23.25M
100.86%
129.79M
458.16%
249.23M
92.02%
283.50M
13.75%
tangible book value per share
1.04
-
-1.04
199.58%
-1.16
12.21%
-0.00
99.78%
0.93
35,976.48%
1.17
25.75%
0.32
72.26%
0.64
99.34%
3.54
449.01%
6.73
90.34%
7.99
18.67%
working capital
39.23M
-
64.19M
63.63%
72.70M
13.26%
108.52M
49.27%
114.30M
5.33%
109.52M
4.18%
97.89M
10.62%
89.69M
8.38%
308.50M
243.97%
404.03M
30.97%
266.57M
34.02%

All numbers in USD (except ratios and percentages)